» Articles » PMID: 30914451

Kinetic and Structural Analysis of Human ALDH9A1

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2019 Mar 28
PMID 30914451
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Aldehyde dehydrogenases (ALDHs) constitute a superfamily of NAD(P)-dependent enzymes, which detoxify aldehydes produced in various metabolic pathways to the corresponding carboxylic acids. Among the 19 human ALDHs, the cytosolic ALDH9A1 has so far never been fully enzymatically characterized and its structure is still unknown. Here, we report complete molecular and kinetic properties of human ALDH9A1 as well as three crystal forms at 2.3, 2.9, and 2.5 Å resolution. We show that ALDH9A1 exhibits wide substrate specificity to aminoaldehydes, aliphatic and aromatic aldehydes with a clear preference for -trimethylaminobutyraldehyde (TMABAL). The structure of ALDH9A1 reveals that the enzyme assembles as a tetramer. Each ALDH monomer displays a typical ALDHs fold composed of an oligomerization domain, a coenzyme domain, a catalytic domain, and an inter-domain linker highly conserved in amino-acid sequence and folding. Nonetheless, structural comparison reveals a position and a fold of the inter-domain linker of ALDH9A1 never observed in any other ALDH so far. This unique difference is not compatible with the presence of a bound substrate and a large conformational rearrangement of the linker up to 30 Å has to occur to allow the access of the substrate channel. Moreover, the αβE region consisting of an α-helix and a β-strand of the coenzyme domain at the dimer interface are disordered, likely due to the loss of interactions with the inter-domain linker, which leads to incomplete β-nicotinamide adenine dinucleotide (NAD) binding pocket.

Citing Articles

A crucial active site network of titratable residues guides catalysis and NAD binding in human succinic semialdehyde dehydrogenase.

Cesaro S, Orlando M, Bettin I, Longo C, Spagnoli G, Polverino de Laureto P Protein Sci. 2024; 34(1):e70024.

PMID: 39731543 PMC: 11681614. DOI: 10.1002/pro.70024.


Gene Expression Dysregulation in Whole Blood of Patients with Infection.

Tsakiroglou M, Evans A, Doce-Carracedo A, Little M, Hornby R, Roberts P Int J Mol Sci. 2024; 25(23).

PMID: 39684365 PMC: 11641058. DOI: 10.3390/ijms252312653.


Differential effects of prenatal alcohol exposure on brain growth reveals early upregulation of cell cycle and apoptosis and delayed downregulation of metabolism in affected offspring.

Sambo D, Kinstler E, Lin Y, Goldman D PLoS One. 2024; 19(11):e0311683.

PMID: 39602444 PMC: 11602053. DOI: 10.1371/journal.pone.0311683.


Deep Learning-Based Identification of Intraocular Pressure-Associated Genes Influencing Trabecular Meshwork Cell Morphology.

Greatbatch C, Lu Q, Hung S, Tran S, Wing K, Liang H Ophthalmol Sci. 2024; 4(4):100504.

PMID: 38682030 PMC: 11046128. DOI: 10.1016/j.xops.2024.100504.


Impaired Detoxification of Trans, Trans-2,4-Decadienal, an Oxidation Product from Omega-6 Fatty Acids, Alters Insulin Signaling, Gluconeogenesis and Promotes Microvascular Disease.

Qian X, Klatt S, Bennewitz K, Wohlfart D, Lou B, Meng Y Adv Sci (Weinh). 2023; 11(4):e2302325.

PMID: 38059818 PMC: 10811472. DOI: 10.1002/advs.202302325.


References
1.
Wen G, Ringseis R, Rauer C, Eder K . The mouse gene encoding the carnitine biosynthetic enzyme 4-N-trimethylaminobutyraldehyde dehydrogenase is regulated by peroxisome proliferator-activated receptor α. Biochim Biophys Acta. 2012; 1819(5):357-65. DOI: 10.1016/j.bbagrm.2012.01.004. View

2.
Mandard S, Muller M, Kersten S . Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci. 2004; 61(4):393-416. PMC: 11138883. DOI: 10.1007/s00018-003-3216-3. View

3.
Ueland P, Holm P, Hustad S . Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med. 2005; 43(10):1069-75. DOI: 10.1515/CCLM.2005.187. View

4.
Zhou Y, Holmseth S, Hua R, Lehre A, Olofsson A, Poblete-Naredo I . The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface. Am J Physiol Renal Physiol. 2011; 302(3):F316-28. DOI: 10.1152/ajprenal.00464.2011. View

5.
Chen V, Arendall 3rd W, Headd J, Keedy D, Immormino R, Kapral G . MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 1):12-21. PMC: 2803126. DOI: 10.1107/S0907444909042073. View